BR112014012016A2 - compostos - Google Patents
compostosInfo
- Publication number
- BR112014012016A2 BR112014012016A2 BR112014012016A BR112014012016A BR112014012016A2 BR 112014012016 A2 BR112014012016 A2 BR 112014012016A2 BR 112014012016 A BR112014012016 A BR 112014012016A BR 112014012016 A BR112014012016 A BR 112014012016A BR 112014012016 A2 BR112014012016 A2 BR 112014012016A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- C07K7/62—Polymyxins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161561361P | 2011-11-18 | 2011-11-18 | |
| PCT/GB2012/052844 WO2013072695A1 (en) | 2011-11-18 | 2012-11-16 | Polymyxin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014012016A2 true BR112014012016A2 (pt) | 2017-05-16 |
Family
ID=47297320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014012016A BR112014012016A2 (pt) | 2011-11-18 | 2012-11-16 | compostos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9234006B2 (enExample) |
| EP (1) | EP2780357A1 (enExample) |
| JP (1) | JP6185920B2 (enExample) |
| KR (1) | KR20140091724A (enExample) |
| CN (1) | CN103946233A (enExample) |
| AU (1) | AU2012338571B2 (enExample) |
| BR (1) | BR112014012016A2 (enExample) |
| CA (1) | CA2855916A1 (enExample) |
| CO (1) | CO7061068A2 (enExample) |
| EA (1) | EA024792B1 (enExample) |
| IL (1) | IL232278A0 (enExample) |
| MX (1) | MX355217B (enExample) |
| SG (1) | SG11201402390PA (enExample) |
| TW (1) | TWI608019B (enExample) |
| WO (1) | WO2013072695A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX355217B (es) | 2011-11-18 | 2018-04-10 | New Pharma Licence Holdings Ltd | Derivados de polimixina. |
| RU2730012C2 (ru) * | 2013-05-22 | 2020-08-14 | Сперо Терапьютикс, Инк. | Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками |
| SI3116897T1 (sl) * | 2014-03-11 | 2022-06-30 | Spero Therapeutics, Inc. | Derivati polimiksina in njihova uporaba v kombinacijskem zdravljenju skupaj z različnimi antibiotiki |
| WO2015149131A1 (en) | 2014-04-01 | 2015-10-08 | Monash University | Polymyxin derivatives as antimicrobial compounds |
| EP3224273A1 (en) * | 2014-11-26 | 2017-10-04 | New Pharma Licence Holdings Limited | Compounds |
| CN107257803B (zh) | 2014-12-16 | 2021-02-05 | 上海盟科药业股份有限公司 | 用于治疗细菌感染的多粘菌素类抗菌剂 |
| FI126143B (en) | 2015-01-15 | 2016-07-15 | Northern Antibiotics Oy | Polymyxine derivative and its uses |
| US9763996B2 (en) | 2015-01-16 | 2017-09-19 | Northern Antibiotics, Ltd. | Polymyxin derivative and uses thereof |
| US10322187B2 (en) | 2015-08-10 | 2019-06-18 | Lehigh University | Reduced toxicity molecular conjugates of anti-fungal agents |
| JP7367950B2 (ja) * | 2015-09-29 | 2023-10-24 | モナッシュ ユニバーシティ | 抗菌性ポリミキシン誘導体化合物 |
| EP3512544B1 (en) * | 2016-09-13 | 2020-10-28 | Centauri Therapeutics Limited | Peptide compounds and therapeutic uses thereof |
| CN108226315B (zh) * | 2016-12-15 | 2022-04-12 | 上海医药工业研究院 | 一种检测多黏菌素e残留量的分析方法 |
| EP3704135A4 (en) * | 2017-11-02 | 2022-04-27 | The University of Queensland | PEPTIDE ANTIBIOTICS |
| TWI851584B (zh) | 2018-06-25 | 2024-08-11 | 新加坡商雲頂新耀股份有限公司 | 化合物 |
| CN111690040A (zh) * | 2019-03-12 | 2020-09-22 | 上海来益生物药物研究开发中心有限责任公司 | 多粘菌素衍生物、其制备方法和应用 |
| JP7045520B2 (ja) * | 2020-01-02 | 2022-03-31 | 上海上薬第一生化薬業有限公司 | ポリミキシンｂ成分又はその塩、その製造方法及び使用 |
| CN115298198A (zh) | 2020-01-21 | 2022-11-04 | 上海盟科药业股份有限公司 | 用于肾相关癌症靶向治疗的新型化合物和组合物 |
| WO2022098950A1 (en) | 2020-11-06 | 2022-05-12 | Spero Therapeutics, Inc. | Compounds |
| CN112755174B (zh) * | 2021-02-26 | 2022-11-18 | 沈阳药科大学 | 多粘菌素衍生物及其制备方法和应用 |
| CN115490757B (zh) * | 2021-06-18 | 2025-10-14 | 华南理工大学 | 活性氧自由基响应的多粘菌素前药化合物及其应用 |
| NL2030897B1 (en) * | 2022-02-11 | 2023-08-18 | Univ Leiden | Antibiotic compounds, formulations and methods of use |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2128617A (en) | 1982-10-06 | 1984-05-02 | Martti Vaara | Polypeptides for use in antibacterial therapy |
| WO1988000950A2 (fr) | 1986-08-06 | 1988-02-11 | Fauchere Jean Luc | Fabrication de conjugues a liaisons de covalence a partir d'un antibiotique et d'un derive non toxique de la polymyxine b |
| US20010021697A1 (en) | 1987-09-14 | 2001-09-13 | Henning Lowenstein | Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| TW274552B (enExample) | 1992-05-26 | 1996-04-21 | Hoechst Ag | |
| US5767068A (en) | 1997-02-13 | 1998-06-16 | Pathogenesis Corporation | Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
| WO2005032470A2 (en) | 2003-09-30 | 2005-04-14 | Kohi Corporation | Compositions and methods for treating burns |
| US20060004185A1 (en) | 2004-07-01 | 2006-01-05 | Leese Richard A | Peptide antibiotics and peptide intermediates for their prepartion |
| BRPI0715095B8 (pt) * | 2006-08-11 | 2021-05-25 | Northern Antibiotics Oy | derivado de polimixina da fórmula geral (i); produto de combinação; composição farmacêutica; método para se sensibilizar bactérias gram-negativas a um agente antibacteriano; método para o desenvolvimento de antibióticos; método para a redução da toxicidade de polimixinas, octapeptinas naturais e seus derivados durante a aplicação das mesmas no tratamento de infecções em um indivíduo; método para melhorar as propriedades farmacocinéticas, de polimixinas, octapeptinas naturais e seus derivados; método para a sensibilização de bactérias gram-negativas clinicamente importantes a um complemento de mecanismo de defesa presente no soro; uso de um derivado; e processo para a preparação de um derivado de polimixina da fórmula (i). |
| US8329645B2 (en) * | 2008-02-08 | 2012-12-11 | Northern Antibiotics Ltd. | Polymyxin derivatives and uses thereof |
| US8193148B2 (en) | 2008-02-08 | 2012-06-05 | Northern Antibiotics Ltd. | Short fatty acid tail polymyxin derivatives and uses thereof |
| FI20085469A0 (fi) * | 2008-02-08 | 2008-05-16 | Northern Antibiotics Oy | Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä |
| ES2334547B1 (es) | 2008-09-10 | 2010-12-03 | Universidad De Barcelona | Compuestos peptidicos antibacterianos. |
| NZ593892A (en) | 2008-12-23 | 2013-11-29 | Biosource Pharm Inc | Antibiotic compositions for the treatment of gram negative infections |
| CN101851270A (zh) | 2009-04-03 | 2010-10-06 | 梁浩 | 一种多粘菌素衍生物及其制备方法 |
| WO2010130007A1 (en) | 2009-05-14 | 2010-11-18 | Monash University | Antimicrobial compounds |
| US8415307B1 (en) | 2010-06-23 | 2013-04-09 | Biosource Pharm, Inc. | Antibiotic compositions for the treatment of gram negative infections |
| WO2012051663A1 (en) | 2010-10-21 | 2012-04-26 | Monash University | Antimicrobial compounds |
| WO2012168820A1 (en) | 2011-06-08 | 2012-12-13 | Pfizer Inc. | Polymyxin derivatives useful as antibacterial agents |
| MX355217B (es) | 2011-11-18 | 2018-04-10 | New Pharma Licence Holdings Ltd | Derivados de polimixina. |
| RU2730012C2 (ru) * | 2013-05-22 | 2020-08-14 | Сперо Терапьютикс, Инк. | Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками |
| SI3116897T1 (sl) * | 2014-03-11 | 2022-06-30 | Spero Therapeutics, Inc. | Derivati polimiksina in njihova uporaba v kombinacijskem zdravljenju skupaj z različnimi antibiotiki |
-
2012
- 2012-11-16 MX MX2014005542A patent/MX355217B/es active IP Right Grant
- 2012-11-16 WO PCT/GB2012/052844 patent/WO2013072695A1/en not_active Ceased
- 2012-11-16 CA CA2855916A patent/CA2855916A1/en not_active Abandoned
- 2012-11-16 EA EA201490634A patent/EA024792B1/ru not_active IP Right Cessation
- 2012-11-16 TW TW101142961A patent/TWI608019B/zh not_active IP Right Cessation
- 2012-11-16 EP EP12797961.5A patent/EP2780357A1/en not_active Withdrawn
- 2012-11-16 AU AU2012338571A patent/AU2012338571B2/en not_active Ceased
- 2012-11-16 BR BR112014012016A patent/BR112014012016A2/pt not_active Application Discontinuation
- 2012-11-16 US US14/356,868 patent/US9234006B2/en active Active
- 2012-11-16 CN CN201280055987.6A patent/CN103946233A/zh active Pending
- 2012-11-16 SG SG11201402390PA patent/SG11201402390PA/en unknown
- 2012-11-16 KR KR1020147014427A patent/KR20140091724A/ko not_active Withdrawn
- 2012-11-16 JP JP2014541753A patent/JP6185920B2/ja not_active Expired - Fee Related
-
2014
- 2014-04-28 IL IL232278A patent/IL232278A0/en unknown
- 2014-06-13 CO CO14128978A patent/CO7061068A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013072695A1 (en) | 2013-05-23 |
| IL232278A0 (en) | 2014-06-30 |
| KR20140091724A (ko) | 2014-07-22 |
| AU2012338571B2 (en) | 2016-06-16 |
| US20150031602A1 (en) | 2015-01-29 |
| EA024792B1 (ru) | 2016-10-31 |
| MX355217B (es) | 2018-04-10 |
| EA201490634A1 (ru) | 2014-12-30 |
| EP2780357A1 (en) | 2014-09-24 |
| MX2014005542A (es) | 2014-10-24 |
| SG11201402390PA (en) | 2014-06-27 |
| TWI608019B (zh) | 2017-12-11 |
| JP6185920B2 (ja) | 2017-08-23 |
| AU2012338571A1 (en) | 2014-05-22 |
| US9234006B2 (en) | 2016-01-12 |
| JP2014533678A (ja) | 2014-12-15 |
| CO7061068A2 (es) | 2014-09-19 |
| CN103946233A (zh) | 2014-07-23 |
| CA2855916A1 (en) | 2013-05-23 |
| TW201326215A (zh) | 2013-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2021037I1 (no) | evinakumab | |
| NL301159I2 (nl) | bimekizumab | |
| NL301081I2 (nl) | Avelumab | |
| FIC20250006I1 (fi) | Flortausipiiri | |
| LT2751083T (lt) | Kvinolono junginys | |
| CO6900145A2 (es) | Compuesto de ciclopropanoamina | |
| DK2744810T4 (da) | Tenofovir-alafenamid-hemifumarat | |
| EP2780065A4 (en) | NASAL MASK SYSTEM | |
| BR112014012016A2 (pt) | compostos | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| CO6910197A2 (es) | Compuestos novedosos | |
| EP2752374A4 (en) | gooseneck | |
| BR112014000879A2 (pt) | deflegmador | |
| EP2701512A4 (en) | Aldosterone synthase inhibitors | |
| CO6960543A2 (es) | 2-tiopirimidinonas | |
| EP2768739A4 (en) | EYEWASH FLUID CONTAINER | |
| BR112013028029A2 (pt) | composto | |
| EP2771685A4 (en) | BIOMARKERS OF CANCER | |
| BR112014015607A2 (pt) | composto | |
| BR112013032866A2 (pt) | composto | |
| BR112013022508A2 (pt) | novos compostos de azaespirodecanona | |
| FR2975867B1 (fr) | Elagueuse | |
| DE112012005313A5 (de) | Leuchtbild | |
| FR2976926B1 (fr) | Caisse-outre | |
| NO2021016I1 (no) | akalabrutinib |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15I | Others concerning applications: loss of priority | ||
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: NOVACTA BIOSYSTEMS LIMITED (GB) , NEW PHARMA LICEN |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |